A detailed history of Core First Bank & Trust transactions in Johnson & Johnson stock. As of the latest transaction made, Core First Bank & Trust holds 16,275 shares of JNJ stock, worth $2.68 Million. This represents 1.61% of its overall portfolio holdings.

Number of Shares
16,275
Previous 16,625 2.11%
Holding current value
$2.68 Million
Previous $2.63 Million 9.55%
% of portfolio
1.61%
Previous 1.65%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $50,533 - $55,223
-350 Reduced 2.11%
16,275 $2.38 Million
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $73,419 - $76,976
-473 Reduced 2.77%
16,625 $2.63 Million
Q4 2023

Mar 18, 2024

SELL
$145.6 - $158.88 $148,657 - $162,216
-1,021 Reduced 5.63%
17,098 $2.68 Million
Q3 2023

Dec 18, 2023

BUY
$155.75 - $174.48 $934 - $1,046
6 Added 0.03%
18,119 $2.82 Million
Q2 2023

Aug 07, 2023

SELL
$154.35 - $166.11 $85,818 - $92,357
-556 Reduced 2.98%
18,113 $3 Million
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $140,476 - $167,641
-930 Reduced 4.75%
18,669 $2.89 Million
Q4 2022

Feb 15, 2023

SELL
$160.2 - $179.79 $51,264 - $57,532
-320 Reduced 1.61%
19,599 $3.46 Million
Q3 2022

Nov 16, 2022

SELL
$161.33 - $179.52 $19,036 - $21,183
-118 Reduced 0.59%
19,919 $3.25 Million
Q2 2022

Aug 16, 2022

BUY
$168.19 - $186.01 $367,326 - $406,245
2,184 Added 12.23%
20,037 $3.56 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $7,906 - $8,979
50 Added 0.28%
17,853 $3.16 Million
Q4 2021

Feb 10, 2022

SELL
$155.93 - $173.01 $74,690 - $82,871
-479 Reduced 2.62%
17,803 $3.05 Million
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $18,249 - $20,280
-113 Reduced 0.61%
18,282 $2.95 Million
Q2 2021

Aug 17, 2021

SELL
$159.48 - $171.07 $31,895 - $34,214
-200 Reduced 1.08%
18,395 $3.03 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $2.55 Million - $2.93 Million
18,595 New
18,595 $2.93 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Core First Bank & Trust Portfolio

Follow Core First Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core First Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Core First Bank & Trust with notifications on news.